The global sales of DNA polymerase are estimated to be worth USD 397.7 million in 2025 and anticipated to reach a value of USD 725.8 million by 2035. Sales are projected to rise at a CAGR of 6.2% over ...

The global neuroendocrine carcinoma treatment market is likely to generate revenue amounting to USD 1,976 million in 2024. Over the assessment period, the industry is projected to expand at an 8.1% ...